Lead & invest in life sciences
From lab to IPO. In 8 live sessions, master building and investing in life-saving biotech and healthtech — from the science to the exit.
- Starts
- Nov 21
- Schedule
- Sat & Sun, 1–4pm ET
- Tuition
- $2,000
As featured in
Great science is not enough
“After 20+ years, I’ve watched incredible tech go nowhere — while modest ideas, with the right structure, grew into billion-dollar exits.”
What makes the difference? It’s not just the tech. It’s the ability to navigate the business of biotech and healthtech:
- Technology proof & scaling
- Regulatory strategy
- IP
- Market validation
- Team
- Fundraising
- Valuation
- Exit
That’s what GATE-X-LS teaches — in four weeks, with real deals on the table.
Walk out able to lead the room
Built for three seats at the table
- Professionals
- Champion cutting-edge initiatives or move into an innovation role in your organization.
- Founders
- A step-by-step guide to building a multi-billion-dollar company from the ground up.
- Investors
- Sharpen your strategy and expand your exposure to Life Sciences.
What you’ll get
Mastering the big picture
A holistic view of the most pressing issues in Life Sciences. Lead key conversations, pitch investors, and represent your company at high-profile events.
Build strategy and execute with precision
Frameworks, skills and templates to craft and execute effective strategies.
Learn from a practitioner, collaborate with peers
Real group cases guided by an experienced investor, alongside peer professionals.
Tailored 1-on-1 sessions
Launching an internal innovation initiative, a strategic plan, a pitch deck or fundraising plan, launching a fund, or evaluating an investment.
Four weeks. Lab to IPO.
Two tracks a week: talks that build the map, cases that make you use it. Squares show which GATELEAD competences each item covers.
Life Sciences Trends
Life Sciences Trends Practicum
Allan Gobbs
Venture Investor · Co-founder & Managing Partner, ATEM Capital
Not a lecturer who used to invest. An investor who still does.
- IPOs
- 5
- M&As
- 4
- IPO return
- 30x
- M&A premium
- 19x
- Years
- 20+
I spent a decade in investment banking, then co-founded ATEM Capital, driving high-profile investments with 5 IPOs and 4 M&As — including a 30x IPO return and a 19x premium in an M&A.
Through investments, board seats and strategic advisory, I’ve worked with some of the brightest minds in the sector.
Today my mission is to help others thrive in Life Sciences — and to build a community of successful, impactful professionals.
Previously at
Allan in the field
On panels, at summits and on air.
Precision Health Summit · The Investment Landscape for Precision Health · 2024
ULFN News · TV interview
eCare21 · Healthtech showcase · New York
Global Health Exhibition · Pharma Vision 2030 Investor Outlook
InterSystems Global Summit
From the cohort
“Great learning experience where a student learns not only from lectures and seminars but also from classmates. Classmates are successful business people with a wide range of professional and international experience.”
KateSenior Manager, Clarivate · Spain“Joining the GATELEAD program in Life Sciences Leadership and Entrepreneurship was an invaluable and essential education. The information provided, the quality of the presentation, and the high-level engagement among students surpassed my expectations.”
AndrewSerial Entrepreneur · Netherlands“Allan, thank you very much for the course! It was very engaging and informative, I got a lot of new information, and most importantly — an understanding of possible directions for further progress!”
EvgeniyaHyTest · Tel Aviv, Israel“There is an amazing balance between overview and practicality; it is great to work with real cases and documents — it immediately opens up the entire depth of the rabbit hole. So far, it is the best online course I’ve ever taken.”
AndrewSerial Entrepreneur · Argentina“Great course, systematic, deep, excellent group of students. Allan, thank you so much!”
AlexSerial Entrepreneur & Investor · Turkey“Great way to work at your own pace and accomplish something after four weeks.”
ArkadyFounding Partner, rpv ventures · Seattle, USA
14 cohorts and counting.
Cohort 15 begins November 21.
$2,000
Tuition. One payment. Invoice provided. Limited seats.
- Dates
- Nov 21–Dec 13, 2026
- Schedule
- Saturdays & Sundays, 1–4pm ET19:00–22:00 CET, 18:00–21:00 in London
- Format
- 8 live sessions · 4 weeks
Included
- 8 live sessions with Allan
- Tailored 1-on-1 sessions
- Full recordings & materials
- Real cases, deal docs, models & templates
- Certificate of completion
- Community of peers
- Step-by-step value-creation guide, pre-seed to exit
- Investor deal-breaker checklist to screen 99% of opportunities without deep diligence
Reserve your spot
No payment now. Leave your details and Allan’s team will reach out with next steps.
Questions, answered
Live is where the magic happens — small-group cases where you put the frameworks to work — so join live when you can. But life happens: every session is recorded, and the recordings and materials are yours.
Every function. Every industry.One framework. Every function. Every industry.
GATE-X-LS is the first column of a larger map: 11 competences across 11 industries, at two depths. Each module is a cell; together they form the full stack of leading and investing in innovation.